AvantGen
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6162 Nancy Ridge Dr 150, San Diego, Cali...Phone Number
(858) 381-5214Website
www.avantgen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AvantGen
AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. Its Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization for therapeutic development. AvantGen has a proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner) libraries and screening technologies and collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing.Explore more
AvantGen Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AvantGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AvantGen, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AvantGen recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AvantGen had a recent Job posting/layoffs
Check if AvantGen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AvantGen launches new products
Website visits: Recent activity has been detected on your website
Check out if AvantGen is spiking on competitors!
Funding: Get notified immidiatlly once AvantGen has new funding data
Congratulate Masked Content for being promoted to Masked Content at AvantGen
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to AvantGen
Compare insights from companies similar to AvantGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AvantGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AvantGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AvantGen.
AvantGen financials insights
Gather financial insights about AvantGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
AvantGen Tech Stack
A closer look at the technologies used by AvantGen
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Award, Video
Event
Events
Event
Events
Event
Events
AvantGen News & Media
Adcentrx and AvantGen Enter a New Partnership with a Three-year, Multi-target Collaboration to Discover Antibodies for Novel Antibody-drug Conjugates
SAN DIEGO, Feb. 14, 2022 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate ("ADC") therapeutic development, and AvantGen, a leader in the use of yeast display technology for human antibody discovery...AvantGen receives an award from the NIH/RADx to commercialize its anti-SARS-CoV-2 nucleocapsid antibodies for ultra-high sensitivity lateral flow assay development
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- AvantGen, a San Diego-based biotech, is a leader in the use of yeast display technology for human and rabbit monoclonal antibody discovery and optimization. AvantGen has received an award from the NIH’s RADx Next program to expedite the commercialization of its high affinity rabbit monoclonal antibodies against the nucleocapsid (N) protein of SARS-CoV-2. A pair of the antibody clones has been evaluated extensively in a rapid lateral flowAvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
SAN DIEGO--(BUSINESS WIRE)--AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development. Using its novel yeast display system and large diverse human antibody libraries, AvantGen has identified a panel of high affinity human monoclonal antibody clonesAvantGen Announces the Rapid Identification and Promising Initial Testing of Antibodies Intended to Diagnose SARS-CoV-2 Infection and Treat COVID-19
SAN DIEGO--(BUSINESS WIRE)--AvantGen Announces the Rapid Identification and Promising Initial Testing of Antibodies Intended to Diagnose SARS-CoV-2 Infection and Treat COVID-19
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding AvantGen
Sign Up For FreeTo access detailed company insights
AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. Its Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization for therapeutic development. AvantGen has a proprietary and robust yeast display syste... Read More
